Advertisement
Demo

FDA expands age indications for GSK's Fluarix Quadrivalent flu shot

Jan 13, 2018 , Drug Store News - Retail
Michael JohnsenWith this approval, providers will be able to use the same dose of Fluarix Quadrivalent (15 ug of hemagglutinin per virus strain in 0.5 mL) to cover all eligible persons from 6 months of age and up.
read more

Read the full story...


Trending healthcare news keywords at this moment

kids healthcare hospitals trump mental aid infographic flu season cancer study opioid care life heart linked brain surgery ceo healthy diabetes drug risk launches morgan conference patients hospital symptoms exercise tax work women age treatment therapy cdc fight year tip sleep big state medicaid list digital pain medical sam fda shows requirements house outbreak helps people patient